ClinicalTrials.gg
RecruitingNCT07298941RESTUpdated Dec 23, 2025

Resilience Enhancement Following Sleep Treatment

A Phase 2 interventional study of Cognitive-behavioral therapy for insomnia (CBTi) and CBTi + Savoring Meditation in Chronic Low Back Pain (CLBP) and Insomnia, sponsored by University of Virginia. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-23.

Sponsored by University of Virginia · Phase 2, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2025; still recruiting 11 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 2
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Sleep Initiation and Maintenance Disorders by University of Virginia — 3 open to participants now, 3 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · University of Virginia.

Planned enrollment
4th of 10
300 · median 123
Started
2025
the only one that year
Phase 2
2 of 10
2 open now
Registered
9th of 10
by date

Among the 10 studies in Sleep Initiation and Maintenance Disorders by University of Virginia, this one is the 4th largest by planned enrollment, is the only one that started in 2025, is one of 2 in phase 2, and was the 9th registered.

Sleep Initiation and Maintenance Disorders

2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

3 of the 10 studies in Sleep Initiation and Maintenance Disorders by University of Virginia are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Sleep Initiation and Maintenance Disorders by University of Virginia, or all of them as a file.
02

Study summary

The primary objective of this study is to evaluate the efficacy of an adaptive intervention targeting both insomnia and positive affect in improving pain outcomes for adults with chronic low back pain (cLBP) and comorbid insomnia. Specifically, the study tests whether augmenting a cognitive behavioral therapy for insomnia (CBTi) program with a meditation intervention (Savoring Meditation) or a Pain Education intervention will result in greater reductions in pain intensity.

Secondary objectives include evaluating improvements in insomnia severity, positive and negative affect, and overall quality of life.

03

Conditions studied

  • Chronic Low Back Pain (CLBP)
  • Insomnia

Keywords

  • chronic low back pain
  • insomnia
  • cognitive-behavioral therapy for insomnia
  • meditation
  • savoring
  • pain
  • internet intervention
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

(1) age >=18 years; (2) report low back pain as ongoing problem >= 3 months and any pain on at least half of the days over the past 6 months (consistent with NIH Consensus Recommendations, other chronic pain problems can be present, but cLBP must be reported as primary); (3) average pain intensity >= 4 over past 7 days on a 0-10 numerical rating scale; (4) sleep-onset insomnia and/or sleep maintenance insomnia and/or late insomnia (>30 minutes of WASO or SOL or waking >30 minutes before desired time for at least 3 nights/week) with presence of insomnia symptoms for >= 6 months, and the sleep disturbance (or associated daytime fatigue) must cause significant distress or impairment in social, occupational, or other areas of functioning to be consistent with DSM 5 criteria (evaluated by phone interview).

Exclusion criteria

Exclusion Criteria:

(1) currently receiving behavioral treatment for insomnia; (2) currently engaging in formal or informal meditation practice on a regular (e.g., weekly) basis; (3) unstable medication use for sleep, pain, or other indication (e.g., changed within the past 3 months); (4) irregular sleep schedules dictated by shift work (i.e., usual bedtimes outside 8:00 p.m.-2:00 a.m. or arising time outside 4:00 a.m.-10:00 a.m.); (4) mental health condition deemed to interfere with study procedures or put the participant at undue risk via semi-structured interview (e.g., screen positive for psychotic disorder) or other untreated sleep disorders (e.g., obstructive sleep apnea, restless legs syndrome) as evaluated by our semi-structured interview based on the Diagnostic Interview for Insomnia (DII); (5) do not have regular internet access; (6) cannot read and speak English (interventions only available in English); and (7) severe cognitive impairment (i.e., score =9 on the Telephone-Assessed Mental State); (8) currently pregnant; 9) unable or unwilling to comply with study protocols, or otherwise determined by the PI to be able to safely participate in the study.

05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
300 participants (estimated)

Study arms

  • Other
    Cognitive-Behavioral Therapy for Insomnia

    Open Label CBTi

    Behavioral: Cognitive-behavioral therapy for insomnia (CBTi)

  • Experimental
    Cognitive-Behavioral Therapy for Insomnia plus Savoring Meditation

    Open label CBTi followed by random allocation to Savoring Meditation

    Behavioral: CBTi + Savoring Meditation

  • Active comparator
    Cognitive-Behavioral Therapy for Insomnia plus Pain Education

    Open label CBTi followed by random allocation to Pain Education

    Behavioral: CBTi + Pain Education

Interventions

  • BehavioralCognitive-behavioral therapy for insomnia (CBTi)

    Sleep Healthy Using the Internet (SHUTi) is a 9-week self-guided, automated, internet-based program that is tailored to the individual and designed to recapitulate the core features of face-to-face CBTi (sleep restriction, stimulus control, cognitive restructuring, sleep hygiene, relapse prevention). It is fully accessible as a web-based application via computers, tablets, and smartphones.

  • BehavioralCBTi + Savoring Meditation

    After first completing CBTi, participants will then complete a course of Savoring Meditation, a meditation training program focused on generating and maintaining positive emotions. Savoring Meditation training comprises four 30-minute training sessions (20-minute meditation training and 10 minutes for Q\&A and session debrief), and will be delivered 1-on-1 by a trained interventionist over remote video-conference.

  • BehavioralCBTi + Pain Education

    After first completing the full course of CBTi, participants will then complete a Pain Education intervention. Delivered 1-on-1 via telehealth, patients will be introduced to the biopsychosocial model of pain, through which they will learn about 1) biological bases for low back pain and chronic pain in general, 2) psychological and 3) social processes that influence pain perception, and 4) pain self-management strategies that are supported by scientific evidence. Pain Education training comprises four 30-minute training sessions.

06

What researchers measure

Primary outcomes

  1. Pain Severity

    0-10 pain severity item from the PEG

    Time frame: Baseline to post-intervention (11 weeks)

Secondary outcomes

  1. Pain Severity

    0-10 pain severity item from the PEG

    Time frame: Baseline to 6 months follow-up

  2. Pain Severity

    0-10 pain severity item from the PEG

    Time frame: Baseline to 12 month follow-up

  3. Pain Interference

    Pain interference items from the PEG

    Time frame: Baseline to Post-Intervention (11 weeks), 6 month follow-up, 12 month follow-up

  4. Disability

    Oswestry Disability Index

    Time frame: Baseline to Post-Intervention (11 weeks), 6 month follow-up, 12 month follow-up

  5. Insomnia Severity

    Insomnia Severity Index

    Time frame: Baseline to Post-Intervention (11 weeks), 6 month follow-up, 12 month follow-up

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — We will consider data sharing requests on a case by case basis, as dictated by institutional data sharing agreements.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Oct 2029, 46 months after the start.

Of 63 phase 2 interventional studies under Sleep Initiation and Maintenance Disorders, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 40. This study's planned 46 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 19, 2025
First posted
Dec 23, 2025
StartActual
Dec 16, 2025
Primary completionEst.
Oct 30, 2029
CompletionEst.
Apr 30, 2030
Last update
Dec 23, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07298941
Responsible party
Patrick Finan, PhD (Professor of Anesthesiology, University of Virginia) — Principal investigator
First posted
Dec 23, 2025
Start date
Dec 16, 2025
Primary completion
Oct 30, 2029 (estimated)
Completion
Apr 30, 2030 (estimated)
Last update
Dec 23, 2025

Study contacts

Zayn Shahzad
Contact
finanlab@uvahealth.org
434-243-5906
Patrick Finan, Ph.D.
principal investigator · University of Virginia School of Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion